Publications

Detailed Information

NUrse-led COntinuum of care for people with Diabetes and prediabetes (NUCOD) in Nepal: study protocol for a cluster randomized controlled trial

DC Field Value Language
dc.contributor.authorXu, Dong ( R-
dc.contributor.authorDev, Rubee-
dc.contributor.authorShrestha, Abha-
dc.contributor.authorZhang, Lingling-
dc.contributor.authorShrestha, Archana-
dc.contributor.authorShakya, Pushpanjali-
dc.contributor.authorHughes, James P-
dc.contributor.authorShakya, Prabin R-
dc.contributor.authorLi, Jinghua-
dc.contributor.authorLiao, Jing-
dc.contributor.authorKarmacharya, Biraj M-
dc.date.accessioned2020-07-16T06:36:01Z-
dc.date.available2020-07-16T15:36:45Z-
dc.date.issued2020-05-29-
dc.identifier.citationTrials. 2020 May 29;21(1):442ko_KR
dc.identifier.issn1745-6215-
dc.identifier.urihttps://hdl.handle.net/10371/168598-
dc.description.abstractBackground
The purpose of this study will be to improve diabetes prevention, access to care and advocacy through a novel cost-effective nurse-led continuum of care approach that incorporates diabetes prevention, awareness, screening and management for low-income settings, and furthermore utilizes the endeavor to advocate for establishing a standard diabetes program in Nepal.

Methods
We will conduct a two-arm, parallel group, stratified cluster randomized controlled trial of the NUrse-led COntinuum of care for people with Diabetes (N1 = 200) and prediabetes (N2 = 1036) (NUCOD) program, with primary care centers (9 outreach centers and 17 government health posts) as a unit of randomization. The NUCOD program will be delivered through the trained diabetes nurses in the community to the intervention group and the outcomes will be compared with the usual treatment group at 6 and 12 months of the intervention. The primary outcome will be the change in glycated hemoglobin (HbA1c) level among diabetes individuals and progression to type 2 diabetes among prediabetes individuals, and implementation outcomes measured using the RE-AIM (reach, effectiveness, adoption, implementation and maintenance) framework. Outcomes will be analyzed on an intention-to-treat basis.

Discussion
The results of this trial will provide information about the effectiveness of the NUCOD program in improving clinical outcomes for diabetes and prediabetes individuals, and implementation outcomes for the organization. The continuum of care model can be used for the prevention and management of diabetes and other noncommunicable diseases within and beyond Nepal with similar context.

Trial registration
ClinicalTrials.gov, NCT04131257. Registered on 18 October 2019.
ko_KR
dc.description.sponsorshipThis study will be conducted under the umbrella of a large implementation project and will be supported by a World Diabetes Foundation (WDF17-1483) grant, a China Medical Board (CMB16–260) grant and Dhulikhel Hospital Kathmandu University. However, the funding organizations will have no role in the design of the study, data collection, data analysis, data interpretation or writing of the report.ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectContinuum of care-
dc.subjectDiabetes-
dc.subjectPrediabetes-
dc.subjectRandomized controlled trial-
dc.subjectImplementation-
dc.titleNUrse-led COntinuum of care for people with Diabetes and prediabetes (NUCOD) in Nepal: study protocol for a cluster randomized controlled trialko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1186/s13063-020-04372-5-
dc.citation.journaltitleTrialsko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2020-06-16T09:37:35Z-
dc.citation.number1ko_KR
dc.citation.startpage442ko_KR
dc.citation.volume21ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share